• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139501
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 01/07/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
An analysis of the product could not be performed since a physical sample was not received for evaluation.A manufacturing record evaluation was performed for the finished device number lot 31437454l and no internal actions related to the complaint was found during the review.However, if the product is received at a later date, the investigation will be updated as applicable.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent an atrial fibrillation ablation with a qdot micro and the patient experienced cardiac tamponade that required pericardiocentesis.After performing pulmonary vein isolation (pvi), box and cavotricuspid isthmus (cti) using qdot micro catheter and lasso 2515 nav eco catheter, cardiac tamponade was confirmed on fluoroscopy, and the patient's vitals decreased.Pericardial drainage was performed.After performing drainage, the patient's vitals stabilized and the patient returned to the intensive care unit (icu).The patient did not require prolonged hospitalization.Septal puncture was performed with a rf needle.No abnormalities observed prior to use of the device nor during use of the product.Additional information was received on 14-jan-2025.No error messages observed on biosense webster equipment during the procedure.The adverse event was discovered during use of biosense webster products.Patient improved.Additional information was received on 21-jan-2025.Act was around 300.One transseptal puncture site was performed during the procedure.No evidence of steam pop.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key21274190
Report Number2029046-2025-00307
Device Sequence Number8071410
Product Code OAE
UDI-Device Identifier10846835016710
UDI-Public(01)10846835016710(11)240907(17)270906(10)31437454L
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P210027
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 01/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD139501
Device Lot Number31437454L
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/07/2025
Initial Report FDA Received Date01/30/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
LASSO NAV 2515,22P SPLITHANDLE.; NGEN PUMP, JAPAN CONFIGURATION.; NGEN RF GENERATOR, JAPAN.; UNK RF NEEDLE.; UNK_CARTO 3.
Outcome Attributed to Adverse Event Required Intervention; Life Threatening;
Patient Age84 YR
Patient SexMale
Patient Weight56 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-